- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03440333
Pulmonary Surfactant(PS) Therapy at High Altitude Area
February 26, 2018 updated by: Ma Juan, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
A Multicenter Study of Pulmonary Surfactant(PS) Therapy in the Treatment of Neonatal Acute Respiratory Distress Syndrome(RDS) at High Altitude Area
The traditional concept believes that the etiology of neonatal respiratory distress syndrome (RDS) is immature development of lung,especially the surfactant synthesis system,and RDS is still one of the major causes of mortality and morbidity in newborns, especially premature infants[1].In recent years, using pulmonary surfactant replacement therapy (PS treatment) in the treatment of respiratory distress syndrome (RDS) is a major breakthrough in neonatal medicine [2].Combined with clinical practice and experience,and through Meta analysis of related randomized controlled trials (RCTs),it confirms that natural surfactant treatment can reduce mortality,the incidence of pulmonary air leaks (pneumothorax and interstitial lung emphysema),and the incidence of bronchopulmonary dysplasia (BPD) or 28-day-old mortality.For RDS in preterm infants whose gestation is <35 weeks ,surfactant replacement therapy is also more effective than in nearly term and full term infants.Therefore, in the analysis of cases of different gestational age groups,the investigators should focus on the study of premature infants cases.Due to less relevant research for using PS treatment to cure newborn RDS in high altitude area,this retrospective study conducts statistics and analysis of recently three-year cases in some hospital of high altitude area,to explore the treatment effect of the high altitude region and the impact of altitude on the treatment.
Study Overview
Detailed Description
in order to explore feasibility and efficacy for PS treatment of newborn RDS in high-altitude area ,and its efficacy at different altitudes, the investigators conduct a multi-center retrospective study of RDS cases in Qinghai and Tibet these two high-altitude area,and use RDS cases under the unique conditions to do statistics and analysis.
Study Type
Observational
Enrollment (Actual)
400
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 minute to 12 hours (CHILD)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
the preterm infants less than 37 weeks were included in the study
Description
Inclusion Criteria:
- diagnosed with respiratory distress syndrome(RDS)
Exclusion Criteria:
- major congenital abnormalities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the intubation rate
Time Frame: one week
|
the effect of PS treatment for NRDS
|
one week
|
the incidence of NRDS in different altitudes
Time Frame: one week
|
different altitudes may result in different rate of NRDS
|
one week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2015
Primary Completion (ACTUAL)
December 31, 2017
Study Completion (ACTUAL)
December 31, 2017
Study Registration Dates
First Submitted
February 3, 2018
First Submitted That Met QC Criteria
February 14, 2018
First Posted (ACTUAL)
February 22, 2018
Study Record Updates
Last Update Posted (ACTUAL)
February 27, 2018
Last Update Submitted That Met QC Criteria
February 26, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- pulmonary surfactant(PS)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surfactant
-
ONYSuspendedChronic Lung Disease | RDS of Prematurity | Surfactant Protein B DeficiencyUnited States
-
Swiss Institute of Allergy and Asthma ResearchUniversity Hospital, ZürichNot yet recruitingControl Condition (PBS) | Household Detergent Exposure | Hand Disinfectant Exposure | Surfactant Exposure | Other Ingredients ExposureSwitzerland
-
Zealand University HospitalUnknownTo Assess Surfactant Levels in Lung Fluid
-
Children's Hospital of Fudan UniversityRecruiting
-
Washington University School of MedicineRecruitingLung Diseases | Lung Diseases, Interstitial | Respiratory Distress Syndrome, Newborn | Pulmonary SurfactantUnited States
-
Children's Hospital of Fudan UniversityNot yet recruitingInterstitial Lung Disease | Surfactant DysfunctionChina
-
Peking University Third HospitalRecruitingMinimal Invasive Surfactant Administration in Two Different Non-invasive Ventilation Modes to NRDS InfantsChina
-
Kafkas UniversityCompletedPneumonia | Covid19 | Surfactant Protein DeficiencyTurkey
-
University of OuluOulu University HospitalRecruitingSurfactant Deficiency Syndrome NeonatalFinland
-
Karolinska InstitutetRecruitingAnalgesia | RDS of Prematurity | Surfactant Deficiency Syndrome NeonatalSweden
Clinical Trials on surfactant
-
Indiana UniversityBLES Biochemicals Inc.Recruiting
-
University Hospital PadovaCompletedRespiratory Distress Syndrome, NewbornItaly
-
Biosurf LLC.Active, not recruitingARDS Due to COVID-19Russian Federation
-
Hamilton Health Sciences CorporationTerminatedHyaline Membrane DiseaseCanada
-
Lawson Health Research InstituteLondon Health Sciences CentreCompleted
-
Anhui Provincial HospitalFirst Affiliated Hospital Bengbu Medical College; The First Affiliated Hospital... and other collaboratorsNot yet recruiting
-
Centre Hospitalier Universitaire de Saint EtienneUnknown
-
Windtree TherapeuticsTerminatedMeconium AspirationUnited States
-
Daping Hospital and the Research Institute of Surgery...Children's Hospital of Chongqing Medical UniversityRecruitingPreterm Birth | Acute Respiratory Distress Syndrome | Respiratory Distress Syndrome | Surfactant DysfunctionChina
-
Zekai Tahir Burak Women's Health Research and Education...CompletedMeconium Aspiration SyndromeTurkey